Friday, November 6, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

AvePoint Shares Hit Fresh Annual Low Amid Analyst Target Cut

Robert Sasse by Robert Sasse
February 3, 2026
in Analysis, Tech & Software, Trading & Momentum
0
AvePoint Stock
0
SHARES
70
VIEWS
Share on FacebookShare on Twitter

Shares of software provider AvePoint plunged to their lowest point in a year during Tuesday’s trading session. The decline was primarily triggered by a downward revision of the price target by analysts at B. Riley Securities, overshadowing the company’s continued operational strength in recurring revenue streams. The stock dropped to an intraday low of $11.28.

Operational Strength Contrasts with Market Sentiment

Financially, AvePoint presents a robust picture that stands in stark contrast to its current share price performance. The company’s Annual Recurring Revenue (ARR) climbed 26% year-over-year to $390 million. Its cloud-based Software-as-a-Service (SaaS) segment was a particular standout, posting impressive growth of 38% and now accounting for 77% of total revenue. AvePoint has set an ambitious long-term goal of reaching $1 billion in ARR by 2029. Despite this solid operational footing, market skepticism persists, as evidenced by a short interest position representing approximately 6.7% of the float as of mid-January.

Analyst Adjustment Weighs on Valuation

The immediate catalyst for the sell-off was an analyst update from B. Riley Securities. The firm lowered its price target on AvePoint from $25 to $22 per share. Notably, the analysts maintained their “Buy” rating on the stock, indicating they still see significant upside potential. However, the market reacted negatively to the adjusted valuation. This move appears to be a delayed response to the company’s latest quarterly earnings report. For the third quarter of fiscal 2025, AvePoint reported revenue of $109.73 million, surpassing forecasts, but its earnings per share of $0.06 narrowly missed the consensus estimate of $0.07.

Should investors sell immediately? Or is it worth buying AvePoint?

Index Inclusion and Technical Context

A technical development is scheduled for Wednesday, with AvePoint shares set to join the Solactive Wolfe Research Long Leg Index at the market open. With a market capitalization hovering around $2.5 billion, the stock is currently trading at the lower end of its 52-week range. This marks a notable pullback from the over-$20 levels it commanded last year. The coming sessions will be crucial in determining whether support can be established around the $11.30 mark.

Key Data Points:
* Shares reached a new 52-week low of $11.28.
* B. Riley Securities reduced its price target to $22 from $25, while keeping a “Buy” rating.
* SaaS revenue increased by 38% in the most recent quarterly report.
* The stock will be added to the Solactive Wolfe Research Long Leg Index tomorrow.

Ad

AvePoint Stock: Buy or Sell?! New AvePoint Analysis from November 5 delivers the answer:

The latest AvePoint figures speak for themselves: Urgent action needed for AvePoint investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 5.

AvePoint: Buy or sell? Read more here...

Tags: AvePoint
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Münchener Rück Stock
Analysis

Munich Re’s Monte Carlo Warning Collides With Wall Street’s Widest Analyst Split in Years

September 7, 2026
Xiaomi Stock
Asian Markets

Xiaomi’s September Tightrope: A Foldable Counterpunch Against Apple While EV Targets Slip

September 7, 2026
Next Post
RLX Technology Stock

RLX Technology Announces Tenfold Dividend Hike Amid Regulatory Headwinds

Rio Tinto Stock

Rio Tinto Faces Crucial Decision Point Amid Merger Speculation

Alliance Data Stock

Bread Financial Demonstrates Robust Financial Health and Strategic Momentum

Recommended

indiemiconductor Stock

Indie Semiconductor Shares Face Technical Headwinds

1 year ago
BioNTech Stock

BioNTech Secures CureVac Acquisition in Landmark mRNA Deal

11 months ago
Food Retailers Market Capitalization

Victorias Secret Reports Strong Earnings Growth and Strategic Initiatives for Future Success

3 years ago

CNH Industrials Financial Report for Q4 2023 Meeting Expectations and Predicting a Slowdown in 2024

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

Pharma Pays for the Rotation While Crypto Hunts for a Floor

Tech Loses $1 Trillion, but the Rest of the Market Holds

Alphabet’s Cloud Doubles, Its Cash Turns Negative, the Stock Sinks

Margins Over Stories: Who Delivers Before the Fed and Big Tech

UPS and Coca-Cola Raise Guidance by Charging More, Not Selling More

Trending

Fastly Stock
Newsletter

Maersk Lifts Guidance a Third Time, and the Stock Still Sinks

by Stephanie Dugan
November 5, 2026
0

Dear readers, Raised guidance was supposed to be the safe harbor of earnings season. Maersk has tested...

AMD Stock

Democrats Win, and the Market Sorts Solar From Musk and Defense

November 4, 2026
Apple Stock

Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

November 3, 2026
Lumentum Stock

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

November 2, 2026
Bitcoin Stock

Pharma Pays for the Rotation While Crypto Hunts for a Floor

October 31, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Maersk Lifts Guidance a Third Time, and the Stock Still Sinks
  • Democrats Win, and the Market Sorts Solar From Musk and Defense
  • Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com